Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancers|August 14, 2025
Therapeutic Cancer Vaccines in Colorectal Cancer: Platforms, Mechanisms, and CombinationsChiara Gallio, Luca Esposito, Alessandro Passardi
Cancer Treatment Reviews|October 30, 2025
Mismatch repair deficiency/microsatellite instability (dMMR/MSI-H) in rectal cancer patients treated with standard neoadjuvant therapy: a systematic review and meta-analysisGianluca Ricco, Chiara Gallio, Nada Benhima, et al.
Frontiers in Oncology|June 13, 2022
Takotsubo Syndrome (TTS) in Onco-Hematologic Patients: Retrospective Analysis and Focus on the Correlation or Not With Anticancer Drugs. Case Reports and Review of the LiteratureManlio Monti, Pietro Cortesi, Roberto Vespignani, et al.
Journal of Clinical Medicine|May 11, 2024
Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal CancerFrancesco Giulio Sullo, Alessandro Passardi, Chiara Gallio, et al.
Frontiers in Oncology|February 27, 2023
Hemophagocytic lymphohistiocytosis in gastric cancer: A rare syndrome for the oncologist. Case report and brief reviewManlio Monti, Giovanni Marconi, Andrea Ambrosini-Spaltro, et al.
Expert Opinion on Biological Therapy|September 4, 2025
Personalized therapy in metastatic colorectal cancer: biomarker-driven use of biologicsFrancesco Sullo, Chiara Gallio, Laura Matteucci, et al.
Nutrients|August 26, 2023
Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric CancerManlio Monti, Andrea Prochowski Iamurri, David Bianchini, et al.
International Journal of Molecular Sciences|October 26, 2024
Multigene Panel Next-Generation Sequencing Techniques in the Management of Patients with Metastatic Colorectal Carcinoma: The Way Forward for Personalized Treatment? A Single-Center ExperienceLaura Matteucci, Francesco Giulio Sullo, Chiara Gallio, et al.
Molecular Therapy. Methods & Clinical Development|June 5, 2023
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive valueIvan Vannini, Tania Rossi, Mattia Melloni, et al.
Scientific Reports|August 9, 2023
Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancerGiorgia Marisi, Irene Azzali, Alessandro Passardi, et al.
Pageof 3